Onco+
Oncology Forecasting Software

Onco+, oncology forecasting software helps you:

Promote insight-led decisions based on transparent forecasts.
Make the black box approach a thing of the past.
Make the impossible possible with the complex variables required to create a forecast already built into your Excel software.
Produce patient flow models to support changing treatment paradigms and the progression of patients.
Reduce any costly third-party involvement needed to produce the forecast.

What is Onco+?

Onco+ is a game-changing Excel add-in, specifically created for Oncology Forecasting. It is the most appropriate methodology for Oncology Forecasting and Patient Flow Modelling. It offers the flexibility to model forecasts on any oncology indication, whether you're creating a new model or developing an existing one.

Onco+ Intuitive

User-friendly design is structured in a step-by-step approach through stages/lines/regimens of forecasting

Details

Onco+ Agile

Onco+ is suited to any cancer type and allows you to make instant changes which reflect the market

Details

Onco+ Engaging

Clear, engaging, easy to interpret data with a consistent look and feel that can be easily shared and reviewed

Details

Onco+ Innovative

Risk analysis, consolidation and a Peak Share Predictor

Details

Who?

Onco+ is designed anyone involved in forecasting in New Product Planning for Oncology Forecasting whether it's in Marketing, Sales, Business Insight, Market Research or Analytics

The J+D team is very experienced and bring a lot of knowledge to their projects.They are very insightful about what sort of things to include in models. Market Analytics Manager, ViiV

J+D's Onco+ tool is a fantastic forecast platform. It is very easy and flexible to use as it is designed as a component of an Excel worksheet. It allows the users to create highly customized forecast model based on the detailed and defined patient flow in all disease areas. The tool has also analytical components including SimScore that will help to have reasonable share assessment like mini-conjoint study, and Monte Carlo Simulation for sensitive and scenario analysis. Great forecasting tool to recommend! Frank Wang, Global Business Analysis Disease Lead, Malignant Haematology